Publicaciones en colaboración con investigadores/as de University of Catania (49)

2024

  1. Characterization and Management of Stable Coronary Artery Disease in Patients Undergoing Transcatheter Aortic Valve Implantation

    Journal of Clinical Medicine, Vol. 13, Núm. 12

  2. Features and outcomes of bailout repeat transcatheter aortic valve implantation (TAVI): the Bailout Acute TAVI-in-TAVI to Lessen Events (BATTLE) international registry

    Clinical Research in Cardiology, Vol. 113, Núm. 1, pp. 68-74

  3. Incidence, Predictors, and Outcomes of Paravalvular Regurgitation After TAVR in Sievers Type 1 Bicuspid Aortic Valves

    JACC: Cardiovascular Interventions, Vol. 17, Núm. 14, pp. 1652-1663

  4. Outcomes and predictors of left ventricle recovery in patients with severe left ventricular dysfunction undergoing transcatheter aortic valve implantation

    EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, Vol. 20, Núm. 8, pp. e487-e495

2023

  1. Comparison of different percutaneous revascularisation timing strategies in patients undergoing transcatheter aortic valve implantation

    EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, Vol. 19, Núm. 7, pp. 589-599

2022

  1. Center Valve Preference and Outcomes of Transcatheter Aortic Valve Replacement: Insights From the AMTRAC Registry

    JACC: Cardiovascular Interventions, Vol. 15, Núm. 12, pp. 1266-1274

  2. Clinical outcomes of transcatheter aortic valve implantation in patients younger than 70 years rejected for surgery: the AMTRAC registry

    EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, Vol. 17, Núm. 16, pp. 1289-1297

  3. Diabetes mellitus in transfemoral transcatheter aortic valve implantation: a propensity matched analysis

    Cardiovascular Diabetology, Vol. 21, Núm. 1

  4. Infective Endocarditis Caused by Staphylococcus aureus After Transcatheter Aortic Valve Replacement

    Canadian Journal of Cardiology, Vol. 38, Núm. 1, pp. 102-112

  5. Management of Myocardial Revascularization in Patients With Stable Coronary Artery Disease Undergoing Transcatheter Aortic Valve Implantation

    Circulation: Cardiovascular Interventions, Vol. 15, Núm. 12, pp. E012417

  6. Mitral Valve Infective Endocarditis after Trans-Catheter Aortic Valve Implantation

    American Journal of Cardiology, Vol. 172, pp. 90-97

  7. Perivalvular Extension of Infective Endocarditis After Transcatheter Aortic Valve Replacement

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 75, Núm. 4, pp. 638-646

  8. Plasma proteins elevated in severe asthma despite oral steroid use and unrelated to Type-2 inflammation

    European Respiratory Journal, Vol. 59, Núm. 2

  9. Recovery of dialysis patients with COVID-19: health outcomes 3 months after diagnosis in ERACODA

    Nephrology Dialysis Transplantation, Vol. 37, Núm. 6, pp. 1140-1151

  10. Sex differences in COVID-19 mortality risk in patients on kidney function replacement therapy

    Scientific Reports, Vol. 12, Núm. 1

  11. Surgical Treatment of Patients With Infective Endocarditis After Transcatheter Aortic Valve Implantation

    Journal of the American College of Cardiology, Vol. 79, Núm. 8, pp. 772-785

  12. Transcatheter aortic valve replacement in obese patients: procedural vascular complications with the trans-femoral and trans-carotid access routes

    Interactive cardiovascular and thoracic surgery, Vol. 34, Núm. 6, pp. 982-989

2021

  1. Clinical triage of patients on kidney replacement therapy presenting with COVID-19: An ERACODA registry analysis

    Nephrology Dialysis Transplantation, Vol. 36, Núm. 12, pp. 2308-2320

  2. Effect of Transcatheter Aortic Valve Replacement on Concomitant Mitral Regurgitation and Its Impact on Mortality

    JACC: Cardiovascular Interventions, Vol. 14, Núm. 11, pp. 1181-1192

  3. Impact of morbid obesity and obesity phenotype on outcomes after transcatheter aortic valve replacement

    Journal of the American Heart Association, Vol. 10, Núm. 12